Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr 14;21(14):4261-7.
doi: 10.3748/wjg.v21.i14.4261.

Biliary tract intraductal papillary mucinous neoplasm: report of 19 cases

Xing Wang  1 , Yun-Qiang Cai  1 , Yong-Hua Chen  1 , Xu-Bao Liu  1
Affiliations

Biliary tract intraductal papillary mucinous neoplasm: report of 19 cases

Xing Wang et al. World J Gastroenterol. .

Abstract

Aim: To gain a better understanding of biliary tract intraductal papillary mucinous neoplasm (BT-IPMN).

Methods: From January 2000 to December 2013, 19 cases of BT-IPMN were retrospectively identified from a total of 343 biliary tract tumors resected in our single institution. Demographic characteristics, clinical data, pathology, surgical strategies, and long-term follow-up were analyzed.

Results: The mean age of the 19 BT-IPMN cases was 53.8 years (range: 25-74 years). The most common symptom was abdominal pain (15/19; 78.9%), followed by jaundice (7/19; 36.8%). Cholangitis was associated with most (16/19; 84.2%) of the BT-IPMN cases. Macroscopically visible mucin was detected in all 19 patients, based on original surgical reports. The most common abnormal preoperative imaging findings for BT-IPMN were bile duct dilation (19/19; 100%) and intraluminal masses (10/19; 52.6%). Thirteen (68.4%) cases involved the intrahepatic bile duct and hilum. We performed left hepatectomy in 11/19 (57.9%), right hepatectomy in 2/19 (10.5%), bile duct resection in 4/19 (21.1%), and pancreatoduodenectomy in 1/19 (5.3%) patients. One (5.3%) patient was biopsied and received a choledochojejunostomy because of multiple tumors involving the right extrahepatic and left intrahepatic bile ducts. Histology showed malignancy in 10/19 (52.6%) patients. The overall median survival was 68 mo. The benign cases showed a non-significant trend towards improved survival compared to malignant cases (68 mo vs 48 mo, P = 0.347). The patient without tumor resection died of liver failure 22 mo after palliative surgery.

Conclusion: BT-IPMN is a rare biliary entity. Complete resection of the tumor is associated with good survival, even in patients with malignant disease.

Keywords: Biliary tract; Cystic tumor; Intraductal papillary mucinous neoplasm; Mucinous tumor; Papillary tumor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Imaging presentation of biliary tract intraductal papillary mucinous neoplasm. A: Magnetic resonance cholangiography shows dilation of proximal biliary tract and a filling defect in the extrahepatic biliary tract (arrow); B: Magnetic resonance imaging shows an intraluminal polypoid lesion originating from the extrahepatic biliary tract (arrow).
Figure 2
Figure 2
Gross appearance of resected specimen. Biliary tract intraductal papillary mucinous neoplasm appeared as a nodular lesion on the distal common bile duct with massive mucin deposition throughout.
Figure 3
Figure 3
Histopathology of biliary tract intraductal papillary mucinous neoplasm. Hematoxylin and eosin staining of A: Common bile duct biliary tract intraductal papillary mucinous neoplasm, composed of papillary proliferation of atypical biliary epithelial cells (magnification × 40); and B: High-grade cytologic atypia and mucin in the numerous goblet cells (magnification × 100).
Figure 4
Figure 4
Kaplan-Meier survival curve. Survival curves for patients with benign (n = 9) and malignant (n = 10) biliary tract intraductal papillary mucinous neoplasms.
See this image and copyright information in PMC

References

    1. Barton JG, Barrett DA, Maricevich MA, Schnelldorfer T, Wood CM, Smyrk TC, Baron TH, Sarr MG, Donohue JH, Farnell MB, et al. Intraductal papillary mucinous neoplasm of the biliary tract: a real disease? HPB (Oxford) 2009;11:684–691. - PMC - PubMed
    1. Sclabas GM, Barton JG, Smyrk TC, Barrett DA, Khan S, Kendrick ML, Reid-Lombardo KM, Donohue JH, Nagorney DM, Que FG. Frequency of subtypes of biliary intraductal papillary mucinous neoplasm and their MUC1, MUC2, and DPC4 expression patterns differ from pancreatic intraductal papillary mucinous neoplasm. J Am Coll Surg. 2012;214:27–32. - PubMed
    1. Zen Y, Fujii T, Itatsu K, Nakamura K, Minato H, Kasashima S, Kurumaya H, Katayanagi K, Kawashima A, Masuda S, et al. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology. 2006;44:1333–1343. - PubMed
    1. Kim HJ, Kim MH, Lee SK, Yoo KS, Park ET, Lim BC, Park HJ, Myung SJ, Seo DW, Min YI. Mucin-hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas. Endoscopy. 2000;32:389–393. - PubMed
    1. Oshikiri T, Kashimura N, Katanuma A, Maguchi H, Shinohara T, Shimizu M, Kondo S, Katoh H. Mucin-secreting bile duct adenoma--clinicopathological resemblance to intraductal papillary mucinous tumor of the pancreas. Dig Surg. 2002;19:324–327. - PubMed

Publication types

MeSH terms

LinkOut - more resources